Literature DB >> 15014746

Practical Principles for the Management of Alzheimer's Disease.

Daniel D. Christensen1.   

Abstract

Alzheimer's disease is a complex disorder that is particularly challenging to treat and manage. Early recognition of Alzheimer's disease is the first step toward providing patients with optimal therapy and the best opportunity for treatment response. Subsequently, physicians will need to address issues that emerge as the disease inevitably progresses. As the number of elderly patients with Alzheimer's disease increases, it becomes increasingly important for the primary care physician-usually the first line of patient contact-to diagnose Alzheimer's disease early, and initiate and manage appropriate long-term cholinesterase inhibitor therapy, which has been shown to provide significant benefits to Alzheimer's disease patients. In this article, discussions of individual patients illustrate commonly encountered situations in the primary care setting.

Entities:  

Year:  2002        PMID: 15014746      PMCID: PMC181227          DOI: 10.4088/pcc.v04n0204

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  28 in total

1.  Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

Authors:  O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Authors:  H Feldman; S Gauthier; J Hecker; B Vellas; P Subbiah; E Whalen
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

3.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

4.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

5.  A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.

Authors:  R C Mohs; R S Doody; J C Morris; J R Ieni; S L Rogers; C A Perdomo; R D Pratt
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

6.  A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Authors:  P N Tariot; P R Solomon; J C Morris; P Kershaw; S Lilienfeld; C Ding
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

7.  Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

Authors:  A Lim; D Tsuang; W Kukull; D Nochlin; J Leverenz; W McCormick; J Bowen; L Teri; J Thompson; E R Peskind; M Raskind; E B Larson
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

8.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

9.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors:  M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal:  BMJ       Date:  1999-03-06

10.  Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

Authors:  T Sunderland; J L Hill; A M Mellow; B A Lawlor; J Gundersheimer; P A Newhouse; J H Grafman
Journal:  J Am Geriatr Soc       Date:  1989-08       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.